FDA GRANTS ORPHAN DRUG DESIGNATION FOR TNFERADE(TM)
Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Depomed Reports Results From Two Phase 3 Clinical Trials Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin(R)
To keep up to date with news from this category use our
Clients in focus...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us